Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
11801
PUT
Trueblue
TBI
$311M
| $44K | ﹤0.01% |
3,000
+1,800
| +150% | +$28K |
|
11802
CALL
AtaiBeckley Inc
ATAI
$2.69B
| $44K | ﹤0.01% |
34,100
+28,300
| +488% | +$48.5K |
|
|
VCSA
11803
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $43.9K | ﹤0.01% |
4,765
+3,195
| +204% | +$38.8K |
|
11804
CALL
Annexon
ANNX
$1B
| $43.9K | ﹤0.01% |
18,600
-32,200
| -63% | -$97.4K |
|
11805
PUT
Vertex
VERX
$2.06B
| $43.9K | ﹤0.01% |
1,900
+200
| +12% | +$4.12K |
|
11806
XBiotech
XBIT
$70.1M
| $43.9K | ﹤0.01% |
10,653
-5,946
| -36% | -$29.8K |
|
|
POTX
11807
PUT
DELISTED
Global X Cannabis ETF
POTX
| $43.9K | ﹤0.01% |
6,600
+1,500
| +29% | +$10.5K |
|
|
ASAI
11808
CALL
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $43.8K | ﹤0.01% |
+3,600
| New | +$47.2K |
|
|
IH
11809
iHuman
IH
$69.5M
| $43.8K | ﹤0.01% |
14,510
+4,146
| +40% | +$12.8K |
|
11810
PUT
Purple Innovation
PRPL
$29.7M
| $43.8K | ﹤0.01% |
1,024
-244
| -19% | -$15.2K |
|
|
HRT
11811
CALL
DELISTED
HireRight Holdings Corporation
HRT
| $43.7K | ﹤0.01% |
4,600
-800
| -15% | -$8.25K |
|
11812
PUT
Insight Enterprises
NSIT
$4.53B
| $43.6K | ﹤0.01% |
300
-500
| -63% | -$74.5K |
|
11813
PUT
Certara
CERT
$1.22B
| $43.6K | ﹤0.01% |
3,000
-200
| -6% | -$3.36K |
|
11814
ARS Pharmaceuticals
SPRY
$562M
| $43.6K | ﹤0.01% |
11,538
-208,810
| -95% | -$1.37M |
|
11815
PUT
Superior Group of Companies
SGC
$208M
| $43.6K | ﹤0.01% |
5,600
-200
| -3% | -$1.73K |
|
11816
CALL
Torrid Holdings
CURV
$219M
| $43.5K | ﹤0.01% |
19,700
+2,800
| +17% | +$6.48K |
|
11817
Dime Commercial Bancshares
DCOM
$1.81B
| $43.5K | ﹤0.01% |
2,181
-37,508
| -95% | -$783K |
|
11818
BioNexus Gene Lab
BGLC
$3.8M
| $43.5K | ﹤0.01% |
+5,175
| New | +$84.3K |
|
11819
Imunon
IMNN
$9.26M
| $43.5K | ﹤0.01% |
3,440
-522
| -13% | -$8.15K |
|
11820
PUT
AdvisorShares Pure Cannabis ETF
YOLO
$32.3M
| $43.4K | ﹤0.01% |
12,700
+3,900
| +44% | +$11.5K |
|
|
EDBL
11821
Edible Garden
EDBL
$1.07M
| – | – |
0
| – | – |
|
11822
Azitra
AZTR
$2.26M
| $43.4K | ﹤0.01% |
145
+67
| +86% | +$37.1K |
|
11823
PUT
IHS Holding
IHS
$2.82B
| $43.3K | ﹤0.01% |
7,800
+4,200
| +117% | +$31.1K |
|
|
KAMN
11824
CALL
DELISTED
Kaman Corp
KAMN
| $43.2K | ﹤0.01% |
2,200
+2,000
| +1,000% | +$44.6K |
|
11825
PUT
Quantum-Si Incorporated
QSI
$162M
| $43.2K | ﹤0.01% |
26,000
-7,900
| -23% | -$19K |
|
Similar funds
Citadel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
- Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.